Leigh MacMillan Archive — Page 57 of 85
-
October 29, 2015
New class of DNA repair enzyme discovered
A new class of DNA repair enzyme has been discovered which demonstrates that a much broader range of damage can be removed from the double helix in ways that biologists did not think were possible. -
October 29, 2015
Inflammation, obesity and diabetes
Vanderbilt study adds to the mounting role for inflammatory signaling in obesity. -
October 21, 2015
Biomarker for intestinal tumors
A new marker could be useful for diagnosing and treating neuroendocrine tumors of the small intestines. -
October 5, 2015
Potential target for lung cancer therapy
The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies. -
October 1, 2015
Collaboration seeks to develop new therapies for bone, other diseases
La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders. -
October 1, 2015
Tolerating a transplant
A new genetic model has generated new strategies for promoting tolerance to transplants – and improving long-term transplant outcomes – in the background of autoimmune disease.